Zhejiang Zhenyuan Share Co.,Ltd. (SHE:000705)
China · Delayed Price · Currency is CNY 9.42
+0.08 (0.86%)
At close: Feb 3, 2026
Zhejiang Zhenyuan Share Revenue
Zhejiang Zhenyuan Share had revenue of 496.36M CNY in the quarter ending September 30, 2025, a decrease of -44.40%. This brings the company's revenue in the last twelve months to 2.67B, down -30.46% year-over-year. In the year 2024, Zhejiang Zhenyuan Share had annual revenue of 3.74B, down -8.91%.
Revenue (ttm)
2.67B
Revenue Growth
-30.46%
P/S Ratio
1.18
Revenue / Employee
1.29M
Employees
2,073
Market Cap
3.15B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.74B | -365.68M | -8.91% |
| Dec 31, 2023 | 4.11B | -39.11M | -0.94% |
| Dec 31, 2022 | 4.15B | 533.43M | 14.77% |
| Dec 31, 2021 | 3.61B | 172.20M | 5.01% |
| Dec 31, 2020 | 3.44B | 196.69M | 6.06% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Int'l Group | 33.54B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Minsheng Healthcare | 744.06M |
| Hubei Guangji Pharmaceutical | 605.87M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Haisen Pharmaceutical | 510.33M |
| Shandong Keyuan Pharmaceutical | 435.52M |